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The murine Harding-Passey melanoma (HPM) has been transplanted for 47
yr in allogeneic mice. It was found to be a very stable system for both melanin
production and cell populations. The intense melanin production was shown to
be typical by electron microscopy (1), and was of the "brown" type corresponding
to the original brown mouse in which it arose (2). In their first paper, Harding
and Passey (2) described two cell types. They suggested that one was "phagocytic
in character." Previous work (1) showed that transplants and primary cultures
consisted of two cell types: the melanocyte and the phagocyte. It appeared that
tumor phagocytes and peritoneal macrophages fed with melanin were identical (3).
Many authors found that macrophages are the effectors of tumor rejection in vivo
and in vitro in allogeneic systems (4-7) and in vitro in a syngeneic system (8).
In this work we report several experiments on the host-melanoma interaction with
a special reference to macrophage-HPM cell interaction.
MATERIALS AND METHODS
Mice. Inbred Balb/C females from the Chester Beatty Research Institute stock,
80-120 days old were used in all the experiments.
Melanoma transplants. HPM was implanted intraperitoneally (ip) as it produced
clean small tumors, covered with the visceral peritoneum. Such tumors were very
suitable for culturing and offered an elegant double compartment system with the
peritoneal cavity (3).
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Melanoma cultures. Primary cultures were prepared from peritoneal nodules
chopped and treated with trypsin and EDTA. The resulting cell suspension was
cultured as a monolayer in Eagle's Dulbecco medium or 199 medium supplemented
with 15% heat inactivated Fetal Bovine Serum, with penicillin and streptomycin,
in Falcon plastic Petri dishes (3.5 cm diam) or flasks (25 cm2). Details will be
published elsewhere (3).
Macrophage cultures. Mouse peritoneal macrophages (PM) were obtained by
injecting, along the midline of the abdomen (the skin was stripped off) 2 ml of
199 medium ip and withdrawing the fluid from both flanks with a syringe. After
seeding 1 X 106 to 2 X 106 PM fcr 2 hr, the unattached cells, mostly lymphocytes,
were removed by six intense washings, according to Evans (9). Then the mono-
layer was cultured in complete medium.
Electron microscopy of cultures. The cultured cells were fixed, embedded, and
cut in situ. At a suitable time, the culture medium was aspirated and the cultures
washed with 199 devoid of serum. Then they were immersed for 30 min at 0°C
in glutaraldehyde-osmium tetroxide mixture according to the method of Hirsch and
Fedorko (10) and washed three to four times in cold 0.1 M cacodylate buffer.
The cells were then dehydrated in cold methyl alcohol, embedded with two changes
of Epon and incubated at 600C for 48 hr. Randomly selected areas were cut out
in small blocks with a saw, the plastic cap overlying the monolayer was pulled
off, and the monolayer cut parallel to the surface using a Diamond knife. On some
occasions cell suspensions were processed in the same way but embedded in cap-
sules. The sections were contrasted with uranyl acetate and lead citrate or with
lead monoxide.
Cytochemistry of cultures. Cultures were fixed in 1% formaldehyde in caco-
dylate buffer 0.1 M pH 7.4 for 4 hr at 40C. The acid phosphatase reaction was
performed according to Barka and Anderson (11) using Naphtol AS-BI phosphate
and hexazonium-pararosanilin as substrate. The tyrosinase reaction was performed
by incubating the fixed cells in 0.1% DL-3,4 dihydroxyphenylalanine (dopa) in
cacodylate buffer 0.1 M pH 7.4 at 370C for 4 hr. The combined acid phosphatase-
dopa reaction was performed according to the method of Mishima (12).
Tritiated thymidine uptake in cultures. Two hours before the time, duplicate
cultures were incubated with complete medium containing 2 jUCi[3H] TdR (sp act
5 Ci/mM Amersham) at 370C. Then the process was performed according to
Temin (13).
Spleen nucleated cell isolation. The spleens were minced in 199 and the cell sus-
pension layered onto a Ficoll-Triosil mixture and centrifuged (14).
Immunization schedule. Tumor cells were irradiated with 10,000 rads using a
60Co source. The tumor cells consisted either of HPM for specific immunization
or L-cells or mammary carcinoma cells (MTV-syngeneic) for nonspecific im-
munization; 106 irradiated cells were suspended in 1 ml 199 without serum and
injected ip three times at 10-day intervals. Controls received 1 ml of 199 alone.
For xenogeneic immunization 106 live cells from the MDCK continuous line were
injected.
RESULTS
Primary cultures of HPM peritoneal transplants. Phase contrast microscopy re-
vealed two cell types which are illustrated in Fig. 1. The first type was more numer-
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FIG. 1. Primary culture of HPM. Phase contrast microscopy after combined acid phosphatase
and tyrosinase reactions. One round phagocyte (P: in the center, strongly positive for acid
phosphatase) is surrounded by melanocytes (strongly positive for tyrosinase) exhibiting long
thin processes. X 130
ous and exhibited long, slim processes. In contrast, the second type consisted of
cells of a more regular shape, containing large brown vacuoles. Electron mi-
croscopy showed that the first contained single melanosomes (Fig. 2) and the sec-
ond, melanosomes enclosed in phagolysosomes only (Fig. 3). The former cell was
considered to be a malignant melanocyte and the latter a phagocyte. The major
difference between these two cell types resulting from six different methods are
summarized in Table 1.
Subcultures of the HPM. After three in vitro passages the resulting trypsinized
population was found to consist only of the melanocyte type as judged from the
above criteria (Table 1). Cells left in the primary culture after trypsinization were
recognized as macrophages according to the same criteria.
Tumor growth after injecting subcultured HPM ip. The purified continuous line
of HPM was injected ip into five batches of ten mice each at the doses of, respec-
tively 102, 103, 104, 105, and 106 HPM cells. On day 30, the mice were killed,
the presence of growth checked, and the tumor weight assessed by addition of the
TABLE 1
THE MAJOR DIFFERENCES BETWEEN A MALIGNANT MELANOCYTE AND A PHAGOCYTE
Harding-Passey melanoma
Method Melanocyte Phagocyte
1. Electron microscopy Single melanosomes Melanin in lysosomes
2. Acid phosphatase Weak, diffuse Strong, granular
3. Tyrosinase Strongly positive Background
4. Morphology in culture Long processes Short processes
5. Trypsin removal in culture No resistance Resistance
6. Phagocytosis Absent Present
7. Thymidine uptake Present Absent
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FIG. 2. HPM melanocyte. Electron micrograph showing many typical single melanosomes
containing osmiophilic granular material of a variable density, enclosed by a single membrane.
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FIG. 3. HPM phagocyte. Electron micrograph showing that all melanosomes are accumulated
in phagolysosomes (PL). There is a prominent golgi (G) and several lysosomes (L).
lp = liposomes. N = nucleus. x14,000MACROPHAGE-MELANOCYTE INTERACTION 373
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FIG. 4. Percentage of take of tumor graft plotted against the number of cultured HPM
melanocytes injected intraperitoneally (ip) 30 days before.
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FIG. 5. Tumor weight (in grams) plotted against the number of cultured HPM melanocytes
injected ip 30 days before.
many peritoneal nodules easily removed from the mesentery. Figure 4 shows that
there was a threshold of 100% take at 105 and that fewer than 103 HPM failed
to grow. Figure 5 shows the correlation between tumor cell dose and resulting
growth.
Study of PM infiltration of HPM nodules and PM population. The degree of
macrophage infiltration in tumors from individual mice was assessed semiquantita-
tively and the number of acid phosphatase positive peritoneal cells (PM) counted
in a hemocytometer. They were recorded according to the time of growth of 105
ip inoculated HPM subcultured cells. Figure 6 shows that after 4-5 wk the small
tumor growth was accompanied by an increased PM population in both tumors
and peritoneal cavity (7). Large tumor growth had intense macrophage infiltration
but the peritoneal population was decreased. Lymphocytes were only occasionallyLEJEUNE
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FIG. 6. Peritoneal macrophages (PM) and tumor macrophages (HPM phagocytes). Number
of PM (acid phosphatase positive cells) in the peritoneal cavity of individual mice, plotted
against the length of the HPM growth and the tumor weight. Semiquantitative assessment of
PM infiltration in tumors (A = large infiltration) and lymphocyte rim around tumor
(0 = presence). The mice (except "no tumor") were injected ip with 10' cultured HPM cells.
found around the tumors and never inside. There was no correlation with macro-
phage infiltration.
Immunization of mice against HPM. As shown in Fig. 8, a consistent degree
of protection against tumor graft was achieved by repeated inoculations of ir-
radiated HPM cells; 28 days after the last shot all mice injected with 106 living
HPM grew tumors, but survival on day 26 of immunized mice was much better.
In the case of mice injected 33 days before with 105 living HPM (which is a
threshold dose, Fig. 4) only one in five mice had a small tumor.
Effect of Immunocompetent Cells on the Tritiated Thymidine Uptake by
HPM in Mixed Cultures
a. Effect of spleen cells. 8 X 106 spleen cells (SC) from immune and control
animals were seeded onto 4 X 104 HPM cells (ratio 200:1) and cultured for 72
hr. Then the SC were washed off and a 2-hr tritiated thymidine incubation was
performed with HPM cells. Seven days after immunization, there was a slight but
specific inhibition of thymidine uptake (Fig. 9 left). However, 31 days after im-
munization, both SC, from mice immunized against HPM and MT, produced a
strong inhibition. In addition the specific SC gave a slightly stronger inhibition than
the nonspecific SC (Fig. 9 right).
b. Effect of peritoneal macrophages. As shown in Fig. 10, normal unstimulated
PM had a marked inhibitory effect on thymidine uptake. In contrast specifically
immunized PM were less inhibitory than control PM 7 days after immunization
and just as inhibiting 31 days after immunization.
Electron microscopy of PM after irradiated tumor cell injections. The repeated
ip injection of irradiated HPM cells was found to produce an enlargement of PM
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FIG. 7a. Light micrograph of tumor of less than 0.5 g 2-3 wk after 10 HPM cells.
Same experiment as in Fig. 6. b. Tumor of less than 0.5 g 4-5 wk after 106.
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FIG. 8. Protection of mice after immunization. Left-number of control and immunized
mice surviving 26 days after ip injection of 106 HPM. Middle-tumor weight of individual
mice 33 days after 10' HPM ip. Right-number of tumor graft take 33 days after 10'
HPM ip.
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FIG. 9. Tritiated thymidine uptake by cultured HPM exposed to spleen cells (SC). Left-SC
from control mice (C) and from mice immunized 7 days before against HPM (a HPM)
and against MDCK cells (a MDCK). Right-SC from control and immunized mice 31
days before against HPM and against mammary tumour (a MT). Mean count per minute
between two determinations.
(Fig. 13) as compared with the control (Figs. 11, 12). This was due to the phago-
cytosis of melanin; 7 days after the last shot the melanin-loaded phagolysosomes
filled the cytoplasm completely (Fig. 14); 31 days after, only several phagolyso-
somes with less melanin were found.
DISCUSSION
The present data indicate that the phagocytes which invade the Harding-Passey
melanoma are host macrophages identical to those of the peritoneum macrophages.
The longer the tumor growth, the more macrophages were found in the tumors.
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FIG. 10. Same experiments as in Fig. 9. Peritoneal macrophages (PM) used in place
of SC.
However, when the tumor demand was intense following tumor growth, the number
of PM in the peritoneal cavity was decreased. This suggests the existence of a bal-
ance between two populations of peritoneal macrophages (PM): tumoral and
peritoneal. The possibility of an immunological role of the PM in our system was
investigated by using PM collected from animals rendered immune. This as-
sumption was proved by in vivo assays showing protection against HPM grafts
and by in vitro assays showing the inhibitory effect of spleen lymphocytes. In con-
trast the in vitro experiments with PM showed an unexplained inhibitory effect
of normal, unstimulated PM. Moreover, PM from specifically immunized animals
exhibited a decrease in this inherent inhibitory effect when taken 7 days after the
last shot. A return to the normal response was observed 31 days afterward. In
addition, PM from nonspecific immunization (aMT) produced more inhibition
than specific PM on day 31. Therefore our results showed a great deal of non-
specificity in immune conditions and a possible inherent inhibitory capacity of nor-
mal macrophages. That macrophages can exert specific inhibition of lymphoma
cells was shown in syngeneic (9) and in allogeneic (6) systems. In contrast, using
solid tumor systems, others (15, 16) found nonspecific macrophage cytotoxicity.
Moreover, a paper presented at this conference dealt with an in vivo protection
against HPM by nonspecific immunization against histocompatibility antigens (17).
In a previous work we found an increase of lysosomes in macrophages from ani-
mals immunized against a syngeneic lymphoma (18). No direct involvement of
lysosomes with specific lymphoma inhibition could be found. In the present system,
which behaves like a syngeneic system, the macrophages from immune animals
exhibited lysosomes filled with melanin. The quantity of such phagolysosomes was
much higher in macrophages obtained 7 days after the last shot as compared with
31 days after, presumably because of melanin degradation (19). It was expected
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FIG. 11. Electron micrograph at low magnification of peritoneal exudate from control
mouse showing peritoneal macrophages (PM), peritoneal lymphocytes (PL) mast cell (MC).
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FIG. 12. Electron micrograph of control PM with kidney-shaped nucleus (sometimes lobu-
lated), typical dendritic processes (DP), and lysosomes (L). Peritoneal lymphocytes (PL)
are smaller with coarse chromatin and smooth membrane. x5300
that melanin would increase the shape and number of lysosomes in macrophages.
Indeed, Cohn and co-workers (20) have established that endocytosis is the main
lysosome inducer in macrophages. Therefore the overloading of macrophage lyso-380) LEJEUNE
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FIG. 14a. High magnification of control PM with typical dendritic processes (DP), pinocytic
vesicles (PV), small dark lysosomes (L), and golgi vesicles and saccules (G) x 13,000.
b. Same magnification as in Fig. 14a. PM fed with melanosomes 7 days after last immuniza-
tion. The cytoplasm is filled with many phagolysosomes (PL) containing aggregates of
melanosomes. There are still several small lysosomes (L).
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in this work. Our results strongly suggest that these phenomenons are to be related
to the general concept of "Reticuloendothelial Blockade'" (21).
The finding that normal macrophages had an inherent thymidine uptake in-
hibitory effect remains to be carefully explored, because of the existence of bac-
terial andotoxin arming phenomenon (22) and antibody-dependent cell-mediated
cytotoxicity (23).
SUMMARY
Transplants and primary cultures of the Harding-Passey Melanoma (HPM)
were found to consist of melanocytes and host macrophages. A pure population
of melanocytes (obtained by subculturing) produced tumors when injected intra-
peritoneally (ip) into Balb/c mice. There was a progressive infiltration of the
tumours by peritoneal macrophages (PM). Repeated inoculations of irradiated
HPM cells ip induced in vivo a protection against HPM graft. In vitro spleen cells
produced a nonspecific inhibition of thymidine uptake by HPM. Normal PM were
found to exhibit a spontaneous nonspecific inhibition. This capacity was impaired
in PM taken from immune animals 7 days after immunization and recovered 31
days after. The relevance of such findings to cell-mediated immunity and lysosome
function are discussed.
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